Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Oura

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Crohn'S & Colitis|February 14, 2012
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in miceTohru Funakoshi, Kenichiro Yamashita, Nobuki Ichikawa, et al.
Cell Transplantation|September 5, 2015
Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow TransplantationTetsu Oura, Dicken S C Ko, Svjetlan Boskovic, et al.
Transplantation|February 24, 2012
Immunomodulatory effect of nuclear factor-κB inhibition by dehydroxymethylepoxyquinomicin in combination with donor-specific blood transfusionRyoichi Goto, Kenichiro Yamashita, Takeshi Aoyagi, et al.
Hepatology (Baltimore, Md.)|January 17, 2016
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantationSatoru Todo, Kenichiro Yamashita, Ryoichi Goto, et al.
JCI Insight|July 23, 2016
Induced regulatory T cells in allograft tolerance via transient mixed chimerismKiyohiko Hotta, Akihiro Aoyama, Tetsu Oura, et al.
Transplantation Direct|May 31, 2021
A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal AllotransplantationWiebke Sommer, Jane M O, Kurt B Pruner, et al.
Science Translational Medicine|April 5, 2023
Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primatesHajime Sasaki, Takayuki Hirose, Tetsu Oura, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Crohn'S & Colitis|February 14, 2012
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in miceTohru Funakoshi, Kenichiro Yamashita, Nobuki Ichikawa, et al.
Cell Transplantation|September 5, 2015
Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow TransplantationTetsu Oura, Dicken S C Ko, Svjetlan Boskovic, et al.
Transplantation|February 24, 2012
Immunomodulatory effect of nuclear factor-κB inhibition by dehydroxymethylepoxyquinomicin in combination with donor-specific blood transfusionRyoichi Goto, Kenichiro Yamashita, Takeshi Aoyagi, et al.
Hepatology (Baltimore, Md.)|January 17, 2016
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantationSatoru Todo, Kenichiro Yamashita, Ryoichi Goto, et al.
JCI Insight|July 23, 2016
Induced regulatory T cells in allograft tolerance via transient mixed chimerismKiyohiko Hotta, Akihiro Aoyama, Tetsu Oura, et al.
Transplantation Direct|May 31, 2021
A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal AllotransplantationWiebke Sommer, Jane M O, Kurt B Pruner, et al.
Science Translational Medicine|April 5, 2023
Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primatesHajime Sasaki, Takayuki Hirose, Tetsu Oura, et al.
Pageof 2